• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Latest News

How Does Psoriasis Influence Sun Tanning Addiction?
How Does Psoriasis Influence Sun Tanning Addiction?

April 29th 2025

Younger patients with moderate to severe psoriasis exhibit risky sun exposure behaviors, raising concerns about tanning addiction and skin cancer risks.

Interview Intersection: Expert Interviews From April 2025
Interview Intersection: Expert Interviews From April 2025

April 29th 2025

Newly Developed Questionnaire Evaluates Quality of Life for Patients with Hair and Scalp Conditions
Newly Developed Questionnaire Evaluates Quality of Life for Patients with Hair and Scalp Conditions

April 29th 2025

FDA Approves First Gene Therapy for RDEB
FDA Approves First Gene Therapy for RDEB

April 29th 2025

Subgroup Case Series Reveals JAKi Efficacy for Black Patients With AA
Subgroup Case Series Reveals JAKi Efficacy for Black Patients With AA

April 29th 2025

Register Now for Revolutionizing Atopic Dermatitis
Introducing Dermatology Times' 2025 Editor in Chief
Pediatric vs Adult Atopic Dermatitis Care
Subscribe Now for Free - eNL
Explore Our Conference Coverage
Subscribe for Free - Print
Advancing AD Treatment: Expert-Led Case Discussions
Breaking Down New Treatment Options in Pediatric Atopic Dermatitis
Stay Informed!
Don't miss the latest in dermatology news
Managing Prurigo Nodularis

Conference Coverage

View All
Christopher Bunick, MD, PhD, Previews RAD 2025: Raising the Bar in Atopic Dermatitis Care
Christopher Bunick, MD, PhD, Previews RAD 2025: Raising the Bar in Atopic Dermatitis Care

April 25th 2025

Upadacitinib Outpaces Dupilumab in Rapid AD Symptom Control
Upadacitinib Outpaces Dupilumab in Rapid AD Symptom Control

April 24th 2025

Exclusive: Outgoing AAD President Seemal Desai, MD, FAAD, on the 3 Issues That Will Shape Dermatology in 2025 (& Beyond)
Exclusive: Outgoing AAD President Seemal Desai, MD, FAAD, on the 3 Issues That Will Shape Dermatology in 2025 (& Beyond)

April 24th 2025

Amy Paller, MD, MS, Discusses Phase 3 Trial Results for Qtorin 3.9% Rapamycin Gel
Amy Paller, MD, MS, Discusses Phase 3 Trial Results for Qtorin 3.9% Rapamycin Gel

April 23rd 2025

Latest Videos

All News

© 2025 MJH Life Sciences

All rights reserved.